From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, Adam K. Wheatley, Danijela Zukancic, Azizah Algarni, Hareth Al-Wassiti, Thomas P. Davis, Colin W. Pouton, Stephen J. Kent, Nghia P. Truong
Topics & Concepts
VaccinationPandemicMedicineInfectious disease (medical specialty)VirologyVaccine efficacyCoronavirus disease 2019 (COVID-19)ImmunologyDiseasePathologyRNA Interference and Gene DeliveryAnimal Virus Infections StudiesSARS-CoV-2 and COVID-19 Research